DBV Technologies's top three insider shareholders as of September 29, 2026 are Bros. Advisors Lp Baker (Director, 14.58Mn shares), Bpifrance Epic (Other, 7.30Mn shares), Pharis Mohideen (Chief Medical Officer, 144.53K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Bros. Advisors Lp Baker | Director, TenPercentOwner | 0 | 14,575,984 | 14,575,984 | 65.6% | 13 Jun, 2022 |
| 2 | Bpifrance Epic | Other | 0 | 7,303,369 | 7,303,369 | 32.9% | 19 Dec, 2025 |
| 3 | Pharis Mohideen | Chief Medical Officer | 144,531 | 0 | 144,531 | 0.7% | 31 Jul, 2026 |
| 4 | Virginie Boucinha | Chief Financial Officer | 70,000 | 0 | 70,000 | 0.3% | 24 Nov, 2025 |
| 5 | Kevin Michael Trapp | Chief Commercial Officer | 55,000 | 0 | 55,000 | 0.2% | 24 Nov, 2025 |
| 6 | Sebastien Robitaille | Chief Financial Officer | 28,500 | 0 | 28,500 | 0.1% | 24 Nov, 2021 |
| 7 | Daniel B Soland | Director | 20,000 | 0 | 20,000 | 0.1% | 03 Aug, 2023 |
| 8 | Daniel Tasse | Chief Executive Officer | 17,094 | 0 | 17,094 | 0.1% | 11 Mar, 2024 |
| 9 | Timothy E Morris | Director | 12,000 | 0 | 12,000 | 0.1% | 28 Aug, 2023 |
| 10 | Adora Ndu | Director | 1,825 | 0 | 1,825 | 0.0% | 08 Feb, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 29 Jul, 2026 | Pharis Mohideen | Chief Medical Officer | Disposed S | 464 | $2.70 | $1.25K | 144,531 | Direct |
| 29 Jan, 2026 | Pharis Mohideen | Chief Medical Officer | Disposed S | 534 | $4.86 | $2.60K | 144,995 | Direct |
| 12 Jan, 2026 | Bros. Advisors Lp Baker | Director | Disposed M | 2,299,656 | $0.00 | $0 | 0 | Indirect |
| 12 Jan, 2026 | Bros. Advisors Lp Baker | Director | Disposed M | 25,005,240 | $0.00 | $0 | 0 | Indirect |
| 12 Jan, 2026 | Bros. Advisors Lp Baker | Director | Acquired M | 2,299,656 | $0.00 | $0 | 2,299,656 | Indirect |
| 12 Jan, 2026 | Bros. Advisors Lp Baker | Director | Acquired M | 25,005,240 | $0.00 | $0 | 25,005,240 | Indirect |
| 17 Dec, 2025 | Bpifrance Epic | Other | Disposed S | 2,036,990 | $4.84 | $9.86Mn | 8,635,472 | Indirect |
| 17 Dec, 2025 | Bpifrance Epic | Other | Disposed S | 40,000 | $5.28 | $211.20K | 8,595,472 | Indirect |
| 18 Dec, 2025 | Bpifrance Epic | Other | Disposed S | 1,292,103 | $4.19 | $5.41Mn | 7,303,369 | Indirect |
| 20 Nov, 2025 | Pharis Mohideen | Chief Medical Officer | Disposed S | 6,496 | $2.88 | $18.71K | 103,153 | Direct |
| 21 Nov, 2025 | Pharis Mohideen | Chief Medical Officer | Disposed S | 1,624 | $2.77 | $4.50K | 101,529 | Direct |
| 21 Nov, 2025 | Pharis Mohideen | Chief Medical Officer | Acquired A | 44,000 | $0.00 | $0 | 145,529 | Direct |
| 21 Nov, 2025 | Pharis Mohideen | Chief Medical Officer | Acquired A | 253,000 | $0.00 | $0 | 253,000 | Direct |
| 21 Nov, 2025 | Kevin Michael Trapp | Chief Commercial Officer | Acquired A | 55,000 | $0.00 | $0 | 55,000 | Direct |
| 21 Nov, 2025 | Virginie Boucinha | Chief Financial Officer | Acquired A | 32,000 | $0.00 | $0 | 70,000 | Direct |
| 21 Nov, 2025 | Daniel Tasse | Chief Executive Officer | Acquired A | 964,000 | $0.00 | $0 | 964,000 | Direct |
| 21 Nov, 2025 | Kevin Michael Trapp | Chief Commercial Officer | Acquired A | 316,250 | $0.00 | $0 | 316,250 | Direct |
| 21 Nov, 2025 | Virginie Boucinha | Chief Financial Officer | Acquired A | 192,000 | $0.00 | $0 | 192,000 | Direct |
| 29 Jul, 2025 | Pharis Mohideen | Chief Medical Officer | Disposed S | 464 | $2.22 | $1.03K | 109,649 | Direct |
| 22 May, 2025 | Pharis Mohideen | Chief Medical Officer | Disposed S | 397 | $1.84 | $730 | 110,113 | Direct |